LAURISTON S. TAYLOR LECTURE: THE QUEST FOR THERAPEUTIC ACTINIDE CHELATORS
- 1 November 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Health Physics
- Vol. 95 (5), 465-492
- https://doi.org/10.1097/01.hp.0000326345.41816.c2
Abstract
All of the actinides are radioactive. Taken into the body, they damage and induce cancer in bone and liver, and in the lungs if inhaled, and U(VI) is a chemical kidney poison. Containment of radionuclides is fundamental to radiation protection, but if it is breached accidentally or deliberately, decontamination of exposed persons is needed to reduce the consequences of radionuclide intake. The only known way to reduce the health risks of internally deposited actinides is to accelerate their excretion with chelating agents. Ethylendiaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) were introduced in the 1950's. DTPA is now clinically accepted, but its oral activity is low, it must be injected as a Ca(II) or Zn(II) chelate to avoid toxicity, and it is structurally unsuitable for chelating U(VI) or Np(V). Actinide penetration into the mammalian iron transport and storage systems suggested that actinide ions would form stable complexes with the Fe(III)-binding units found in potent selective natural iron chelators (siderophores). Testing of that biomimetic approach began in the late 1970's with the design, production, and assessment for in vivo Pu(IV) chelation of synthetic multidentate ligands based on the backbone structures and Fe(III)-binding groups of siderophores. New efficacious actinide chelators have emerged from that program, in particular, octadentate 3,4,3-LI(1,2-HOPO) and tetradentate 5-LIO(Me-3,2-HOPO) have potential for clinical acceptance. Both are much more effective than CaNa3-DTPA for decorporation of Pu(IV), Am(III), U(VI), and Np(IV,V), they are orally active, and toxicity is acceptably low at effective dosage.Keywords
This publication has 103 references indexed in Scilit:
- Experimental Evidence for a Second Coordination Sphere Water Molecule in the Hydration Structure of YbDTPA – Insights for a Re-Assessment of the Relaxivity Data of GdDTPAEuropean Journal of Inorganic Chemistry, 2000
- Efficacy of 3,4,3-LIHOPO for reducing neptunium retention in the rat after simulated wound contaminationInternational Journal of Radiation Biology, 2000
- Efficacy of 3,4,3-LIHOPO for Reducing the Retention of Uranium in Rat after Acute AdministrationInternational Journal of Radiation Biology, 1995
- Comparative Efficacies of 3,4,3-LIHOPO and DTPA for Enhancing the Excretion of Plutonium and Americium from the Rat After Simulated Wound Contamination as NitratesInternational Journal of Radiation Biology, 1993
- Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligandsJournal of Medicinal Chemistry, 1988
- Identification of transferrin as the principal neptunium-binding protein in the blood serum of ratsInternational Journal of Nuclear Medicine and Biology, 1985
- Coordination isomers of biological iron transport compounds III. (1) transport of A-cis-chromic desferriferrichrome by Ustilago sphaerogenaBiochemical and Biophysical Research Communications, 1974
- Potentiometric determination of stability constants of bivalent and rare earth metal complexes with 2,3-pyridinediolJournal of Inorganic and Nuclear Chemistry, 1970
- On the complex forming tendency of phenolic hydroxyl with UO22+Journal of Inorganic and Nuclear Chemistry, 1965
- A Crystalline Organo-iron Pigment from a Rust Fungus (Ustilago sphaerogena)1Journal of the American Chemical Society, 1952